We Can Now Customize Cancer Cures, Tumor by Tumor
But can any company afford to manufacture one-off medical treatments?
By Adam Piore
The first time someone pitched Genentech’s senior leadership on a personalized cancer vaccine, it did not go well. “I thought there was going to be a riot,” Ira Mellman, then Genentech’s head of research oncology, recalls.